Robert J. Kreitman
0000-0001-5141-1844
Publication & Citation Trends
Publications
0 total
COVID-19 vaccination in patients with classic and variant hairy cell leukemia OA
Cited by 0
Semantic Scholar
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms OA
Cited by 9
Semantic Scholar
Rituximab Reduces Immunogenicity and Increases Complete Remissions without Minimal Residual Disease in Relapsed/Refractory Hairy Cell Leukemia Patients Receiving Moxetumomab Pasudotox
Cited by 0
Semantic Scholar
Non-V600E BRAF Gene Alterations in Hairy Cell Leukemia
Cited by 1
Semantic Scholar
A Randomized Phase 2 Trial of 2nd-Line Cladribine with Concurrent or Delayed Rituximab in Patients with Classic Hairy Cell Leukemia
Cited by 0
Semantic Scholar
Effect of rituximab on remissions without minimal residual disease and immunogenicity in patients with relapsed/refractory hairy cell leukemia receiving moxetumomab pasudotox.
Cited by 1
Semantic Scholar
Characterization of B‐cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS‐CoV‐2 infection OA
Cited by 0
Semantic Scholar
S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY. OA
Cited by 0
Semantic Scholar
Research Topics
Toxin Mechanisms and Immunotoxins
(188)
Chronic Lymphocytic Leukemia Research
(139)
Transgenic Plants and Applications
(106)
Monoclonal and Polyclonal Antibodies Research
(91)
Lymphoma Diagnosis and Treatment
(63)
Affiliations
University of Maryland, Baltimore
Atrium Health Wake Forest Baptist
National Institutes of Health
Center for Biologics Evaluation and Research
Memorial Sloan Kettering Cancer Center